Aardvark Therapeutics, Inc.
AARD
$5.39
$0.020.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -100.46% | -290.15% | -163.66% | -327.46% | -330.13% |
| Total Depreciation and Amortization | 25.00% | 25.00% | 650.00% | 150.00% | 111.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 533.62% | 273.02% | 101.59% | -10.16% | -12.93% |
| Change in Net Operating Assets | -182.58% | -940.63% | 273.83% | -638.87% | 17.44% |
| Cash from Operations | -117.55% | -307.84% | -133.55% | -420.00% | -568.43% |
| Capital Expenditure | 100.00% | 20.00% | 2.15% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 304.41% | -- | -- | -- | -- |
| Cash from Investing | 304.30% | 585,020.00% | 10,217.20% | -2,252,380.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 68.10% | 1.18% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 96.26% | -- | -- |
| Cash from Financing | 127.02% | 167.19% | -100.09% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 137.63% | 441.04% | -100.64% | -1,500.77% | -1,685.12% |